Article
MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy.
Pharmacogenomics - 1 Jul 2017
Vos Karin, Sciuto Carlotta Lo, Piedade Rita, Ashton Michael, Björkman Anders, Ngasala Billy, Mårtensson Andreas, Gil José Pedro
Abstract excerpt
AIM: To investigate the potential involvement of the hepatic ATP-binding cassette transporters MRP2 and MDR1 in the disposition of lumefantrine (LUM) among patients with uncomplicated Plasmodium falciparum malaria. MATERIALS & METHODS: The tag SNPs MDR1/ABCB1 C3435T and MRP2/ABCC2 C1515Y were determined in two artemether-LUM clinical trials, including a pharmacokinetic/pharmacodynamic study focused on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
